Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bahn

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Nature Clinical Practice. Endocrinology & Metabolism|August 30, 2008
Is radioiodine more likely than antithyroid drugs to worsen ophthalmopathy in patients with Graves disease?Rebecca S Bahn
The Western Journal of Medicine|June 1, 1993
The enigma of Graves' ophthalmopathyR S Bahn
International Archives of Allergy and Immunology|March 1, 1995
The fibroblast is the target cell in the connective tissue manifestations of Graves' diseaseR S Bahn
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 1, 1995
Assessment and management of the patient with Graves' ophthalmopathyR S Bahn
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 12, 2015
Current Insights into the Pathogenesis of Graves' OphthalmopathyR S Bahn
Journal of Endocrinological Investigation|May 29, 2004
TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathyR S Bahn
Endocrinology and Metabolism Clinics of North America|June 30, 2000
Understanding the immunology of Graves' ophthalmopathy. Is it an autoimmune disease?R S Bahn
Journal of Translational Internal Medicine|February 14, 2017
Graves' disease syndrome: a need for unified therapyRebecca S Bahn
Thyroid : Official Journal of the American Thyroid Association|April 16, 2002
Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathyRebecca S Bahn
Expert Review of Clinical Pharmacology|December 14, 2012
Emerging pharmacotherapy for treatment of Graves' diseaseRebecca S Bahn
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Nature Clinical Practice. Endocrinology & Metabolism|August 30, 2008
Is radioiodine more likely than antithyroid drugs to worsen ophthalmopathy in patients with Graves disease?Rebecca S Bahn
The Western Journal of Medicine|June 1, 1993
The enigma of Graves' ophthalmopathyR S Bahn
International Archives of Allergy and Immunology|March 1, 1995
The fibroblast is the target cell in the connective tissue manifestations of Graves' diseaseR S Bahn
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 1, 1995
Assessment and management of the patient with Graves' ophthalmopathyR S Bahn
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 12, 2015
Current Insights into the Pathogenesis of Graves' OphthalmopathyR S Bahn
Journal of Endocrinological Investigation|May 29, 2004
TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathyR S Bahn
Endocrinology and Metabolism Clinics of North America|June 30, 2000
Understanding the immunology of Graves' ophthalmopathy. Is it an autoimmune disease?R S Bahn
Journal of Translational Internal Medicine|February 14, 2017
Graves' disease syndrome: a need for unified therapyRebecca S Bahn
Thyroid : Official Journal of the American Thyroid Association|April 16, 2002
Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathyRebecca S Bahn
Expert Review of Clinical Pharmacology|December 14, 2012
Emerging pharmacotherapy for treatment of Graves' diseaseRebecca S Bahn
Pageof 19